Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Leuprolide to Treat Prostate Cancer

ClinicalTrials.gov ID: NCT00626431

Public ClinicalTrials.gov record NCT00626431. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 10:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Open-Label, Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of Two 6-Month Leuprolide Formulations, in Subjects With Prostatic Adenocarcinoma

Study identification

NCT ID
NCT00626431
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
310 participants

Conditions and interventions

Interventions

  • Leuprolide acetate - Formulation A Drug
  • Leuprolide acetate - Formulation B Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Jul 31, 2009
Completion
Aug 31, 2009
Last update posted
Jul 18, 2011

2008 – 2009

United States locations

U.S. sites
63
U.S. states
24
U.S. cities
61
Facility City State ZIP Site status
Site Reference ID/Investigator# 8696 Birmingham Alabama 35209
Site Reference ID/Investigator# 8681 Homewood Alabama 35209
Site Reference ID/Investigator# 8569 Anchorage Alaska 99508
Site Reference ID/Investigator# 9709 Phoenix Arizona 85013
Site Reference ID/Investigator# 8662 Sierra Vista Arizona 85635
Site Reference ID/Investigator# 8656 Tucson Arizona 85710
Site Reference ID/Investigator# 9705 Little Rock Arkansas 72211
Site Reference ID/Investigator# 8691 Anaheim California 92801
Site Reference ID/Investigator# 8566 Atherton California 94027
Site Reference ID/Investigator# 8686 Fresno California 93720
Site Reference ID/Investigator# 8698 Laguna Hills California 92653
Site Reference ID/Investigator# 9703 Long Beach California 90806
Site Reference ID/Investigator# 8674 Los Angeles California 90015
Site Reference ID/Investigator# 8650 Tarzana California 91356
Site Reference ID/Investigator# 8699 Torrance California 90505
Site Reference ID/Investigator# 8668 Denver Colorado 80211
Site Reference ID/Investigator# 8646 Englewood Colorado 80113
Site Reference ID/Investigator# 8652 Middlebury Connecticut 06762
Site Reference ID/Investigator# 8697 New Britain Connecticut 06052
Site Reference ID/Investigator# 8655 Aventura Florida 33180
Site Reference ID/Investigator# 8648 Daytona Beach Florida 32114
Site Reference ID/Investigator# 8660 New Smyrna Beach Florida 32168
Site Reference ID/Investigator# 8658 Orange City Florida 32763
Site Reference ID/Investigator# 8664 Orlando Florida 32803
Site Reference ID/Investigator# 8651 Saint Augustine Florida 32086
Site Reference ID/Investigator# 8661 St. Petersburg Florida 33710
Site Reference ID/Investigator# 8568 Tallahassee Florida 32308
Site Reference ID/Investigator# 8679 Wellington Florida 33414
Site Reference ID/Investigator# 8562 West Palm Beach Florida 33407
Site Reference ID/Investigator# 8670 Roswell Georgia 30076
Site Reference ID/Investigator# 9708 Thomasville Georgia 31799
Site Reference ID/Investigator# 8693 Fort Wayne Indiana 46825
Site Reference ID/Investigator# 8690 Newburgh Indiana 47630
Site Reference ID/Investigator# 8565 Overland Park Kansas 66211
Site Reference ID/Investigator# 8676 Greenbelt Maryland 20770
Site Reference ID/Investigator# 8653 Las Vegas Nevada 89148
Site Reference ID/Investigator# 8667 Lawrenceville New Jersey 08648
Site Reference ID/Investigator# 8665 New York New York 10016
Site Reference ID/Investigator# 8657 Poughkeepsie New York 12601
Site Reference ID/Investigator# 9702 The Bronx New York 10461
Site Reference ID/Investigator# 8680 Charlotte North Carolina 28209
Site Reference ID/Investigator# 8673 Concord North Carolina 28025
Site Reference ID/Investigator# 8666 Raleigh North Carolina 27607
Site Reference ID/Investigator# 8570 Salisbury North Carolina 28144
Site Reference ID/Investigator# 8644 Winston-Salem North Carolina 27103
Site Reference ID/Investigator# 8663 Cincinnati Ohio 45212
Site Reference ID/Investigator# 8567 Columbus Ohio 43220
Site Reference ID/Investigator# 8678 Bethany Oklahoma 73008
Site Reference ID/Investigator# 8563 Bala-Cynwyd Pennsylvania 19004
Site Reference ID/Investigator# 8692 Lancaster Pennsylvania 17604-3200
Site Reference ID/Investigator# 8689 Myrtle Beach South Carolina 29572
Site Reference ID/Investigator# 8643 Germantown Tennessee 38138
Site Reference ID/Investigator# 8695 Germantown Tennessee 38138
Site Reference ID/Investigator# 8685 Memphis Tennessee 38119
Site Reference ID/Investigator# 8564 Nashville Tennessee 37209
Site Reference ID/Investigator# 8645 Nashville Tennessee 37232-2765
Site Reference ID/Investigator# 8641 Dallas Texas 75231
Site Reference ID/Investigator# 8675 Houston Texas 77024
Site Reference ID/Investigator# 8684 San Antonio Texas 78229
Site Reference ID/Investigator# 8649 Tyler Texas 75701
Site Reference ID/Investigator# 8683 Salt Lake City Utah 84107
Site Reference ID/Investigator# 8672 Norfolk Virginia 23502
Site Reference ID/Investigator# 8669 Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00626431, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2011 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00626431 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →